BamSEC and AlphaSense Join Forces
Learn More

Cyclacel Pharmaceuticals Inc.

NASDAQ: CYCC    
Share price (12/24/24): $0.32    
Market cap (12/24/24): $1.997 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.5
from S-1 1 page Certificate of Correction
12/34/56
EX-3.4
from S-1 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cyclacel Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Bylaws of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 16 pages Cyclacel Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Terms of Preferred Stock
12/34/56
EX-3.01
from 8-K 16 pages Second Amended & Restated Bylaws of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cyclacel Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 22 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.5
from S-1/A 21 pages Terms of Preferred Stock
12/34/56
EX-3.5
from S-1/A 21 pages Terms of Preferred Stock
12/34/56
EX-3.1
from 10-Q 4 pages Amended and Restated Certificate of Incorporation of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 24 pages Amended & Restated Bylaws of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-K 6 pages Amended and Restated Certificate of Incorporation of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 6 pages Amended and Restated Certificate of Incorporation of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.01
from 8-K 1 page Cyclacel Pharmaceuticals, Inc. Amendment No. 2 to the Amended and Restated Bylaws
12/34/56
EX-3.2
from 10-K 24 pages Amended & Restated Bylaws of Cyclacel Pharmaceuticals, Inc
12/34/56
EX-3.01
from 8-K 1 page Cyclacel Pharmaceuticals, Inc. Amendment No. 1 to the Amended and Restated Bylaws
12/34/56
EX-3.3.1
from 10-Q ~5 pages Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Xcyte Therapies, Inc
12/34/56
EX-3.4
from 10-Q 2 pages Certificate of Correction to the Certificate of the Powers, Designations, Preferences and Rights of the 6% Convertible Exchangeable Preferred Stock ($0.001 Par Value) (Cumulative Dividend, Liquidation Preference $10 Per Share) of Xcyte Therapies, Inc. (Pursuant to Section 103(f) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.2
from 8-K 36 pages Certificate of the Powers, Designations, Preferences and Rights of the 6% Convertible Exchangeable Preferred Stock ($0.001 Par Value) (Cumulative Dividend, Liquidation Preference $10 Per Share) of Xcyte Therapies, Inc. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56